Exosome Platform
Manufacturing platform for exosome therapeutics
mP³EXO™ platform is a resultant of ExoStemTech's accumulated know-how for exosome production and quality control, enabling safe and effective mass-production of exosome therapeutics.
mP³EXO™ platform conforming to cGMP standard can cover production from investigational drugs to commercialized ones.
Exosome drug production process
Cell
Cell Culture
Exosome
Drug Product
Stem cell banking (MCB/WCB)
We strictly control the quality of stem cells, "the natural factory that produces exosomes", to produce exosome therapeutics with high-quality. ExoStemTech established stem cell banks and manages cell quality through careful donor and cellular substrate evaluation.
Upstream process (cell culture)
Characteristics and cellular behaviors of stem cells can be affected by their surrounding environments. The stemness of stem cells can be strengthened and their specific effective factors can be increased by controlling the culture conditions.
Downstream process (purification)
Impurities in exosome therapeutcis can cause unexpected side-effects.
The exosomes are purificed and isolated by using our filtration-based purification process to produce the safe and effective exosome therapeutics.
Formulation & Filling
The exosomes are mixed with chemical preservative to maintain the exosome characteristics and to store in long-term. Our various formulations of exosomes can allow to be administrated to the human body through injection, inhalation and oral administration.
Quality control
We strictly manage the quality of exosome therapeutics from cell banks to exosome therapeutics.
성상
Appearance
순도 시험
Purity
확인 시험
Identification
형태 분석
Morphology
Exosome Therapeutics
정량 분석
Quantification
역가 시험
Potency
안전성 평가
Safety
안정성
Stability
내부인자 프로파일링
Cargo profiling